HLXB · Categories · Form 4

HLXB - SEC Form 4 insider transactions

Helix Acquisition Corp. II (HLXB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for HLXB

• 241d
  SEC Form 4 filed by Director Tipirneni Praveen P.

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Director Mccormick Frank

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Director Bauer Jake

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Chief Scientific Officer Beltran Pedro

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Chief Med & Dev Officer Ben Yong

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Chief Executive Officer Wallace Eli M.

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 241d
  SEC Form 4 filed by Chief Financial Officer Mehra Uneek

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 257d
  Director Chen Bihua converted options into 4,172,126 shares, returned 152,940 shares to the company and was granted 10,950,408 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 258d
  SEC Form 4 filed by Chief Legal Officer Obradovic Nebojsa

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 258d
  SEC Form 4 filed by Chief Financial Officer Tripp Caleb

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 258d
  Former Director Holman Albert A Iii converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 258d
  Former Director Mckenna Mark C. converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 258d
  Former Director Schmid John P. converted options into 30,000 shares (SEC Form 4)

  4 - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Issuer)
• 440d
  SEC Form 4 filed by Director Helix Holdings Ii Llc

  4 - Helix Acquisition Corp. II (0001869105) (Issuer)
• 440d
  SEC Form 4 filed by CEO and Chairperson Chen Bihua

  4 - Helix Acquisition Corp. II (0001869105) (Issuer)

Other HLXB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends